XML 136 R107.htm IDEA: XBRL DOCUMENT v3.20.1
Parent Only Condensed Financial Information - Schedule of Parent Only Condensed Statements of Cash Flows (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities:      
Net income $ 39,209 $ 36,105 $ 25,528
Net cash provided by (used in) operating activities 476,468 (84,648) 28,783
Cash flows from investment activities:      
Net cash acquired (outlay) in connection with acquisition   25,073  
Net cash used in investing activities (219,353) (322,390) (264,446)
Cash flows from financing activities:      
Issuance of subordinated debentures, net of issuance costs   54,018  
Issuance of common stock, net of issuance costs     60,210
Dividends paid (8,033) (5,753) (5,118)
Common stock repurchased, net of repurchased costs (3,190)    
Stock options exercised 2,817 9,629 2,296
Net cash (used in) provided by financing activities (223,037) 404,675 266,998
Net increase (decrease) in cash and cash equivalents 34,078 (2,363) 31,335
Cash and cash equivalents at beginning of period 147,685 150,048 118,713
Cash and cash equivalents at end of period 181,763 147,685 150,048
RBB Bancorp      
Cash flows from operating activities:      
Net income 39,209 36,105 25,528
Net amortization of other 508 268 235
Provision for deferred income taxes 513 (1,905) 1,807
Undistributed income of subsidiaries (45,398) (39,726) (27,763)
Change in other assets and liabilities (1,981) 3,492 (3,923)
Net cash provided by (used in) operating activities (7,149) (1,766) (4,116)
Cash flows from investment activities:      
Net cash acquired (outlay) in connection with acquisition   (41,358)  
Investment in subsidiaries   (15,000) (25,000)
Net cash used in investing activities   (56,358) (25,000)
Cash flows from financing activities:      
Issuance of subordinated debentures, net of issuance costs   54,018  
Issuance of common stock, net of issuance costs     60,210
Dividends paid (8,033) (5,753) (5,118)
Common stock repurchased, net of repurchased costs (3,190)    
Stock options exercised 2,817 9,630 2,296
Net cash (used in) provided by financing activities (8,406) 57,895 57,388
Net increase (decrease) in cash and cash equivalents (15,555) (229) 28,272
Cash and cash equivalents at beginning of period 45,540 45,769 17,497
Cash and cash equivalents at end of period $ 29,985 $ 45,540 $ 45,769